Existing Cancer Therapy in Narrow Use Shows Significant Activity Against Other Cancers - Newswise

A drug currently used in just 1% of cancers has significant potential against the remaining 99%, according to a new study from UH Seidman Cancer Center and Case

CLEVELAND—A drug used to target IDH1 mutations in select cancers also appears to inhibit the wild-type form of the enzyme, under certain conditions. This feature explains why a large group of differe… [+9296 chars]

full article...